Company Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-24 pm EDT 5-day change 1st Jan Change
147 USD -1.82% Intraday chart for Johnson & Johnson -4.96% -6.23%

Business Summary

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).

Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).

Number of employees: 131,900

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Medicine
64.3 %
52,563 55.4 % 54,759 64.3 % +4.18%
MedTech
35.7 %
27,427 28.9 % 30,400 35.7 % +10.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
54.5 %
48,580 51.2 % 46,444 54.5 % -4.40%
Europe
24.0 %
23,449 24.7 % 20,410 24.0 % -12.96%
Asia-Pacific, Africa
16.2 %
16,789 17.7 % 13,756 16.2 % -18.07%
Western Hemisphere Excluding United States
5.3 %
6,125 6.5 % 4,549 5.3 % -25.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 88-12-31
Director of Finance/CFO 57 97-12-31
Chief Tech/Sci/R&D Officer 58 19-11-04
Chief Tech/Sci/R&D Officer 74 06-12-31
Investor Relations Contact - 21-10-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 47 18-12-31
Corporate Officer/Principal 52 -
General Counsel 53 05-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 19-04-24
Director/Board Member 72 14-06-18
Director/Board Member 70 09-10-21
Director/Board Member 64 19-12-04
Director/Board Member 60 13-10-14
Chief Executive Officer 61 88-12-31
Director/Board Member 58 22-02-14
Director/Board Member 59 Nov. 29
Director/Board Member 62 19-12-04
Director/Board Member 63 20-12-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,119,799,183 2,404,640,893 ( 77.08 %) 713,120,000 ( 22.86 %) 77.08 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.500 %
228,938,504 9.500 % 33 613 M $
BlackRock Advisors LLC
6.048 %
145,731,837 6.048 % 21 396 M $
133,519,781 5.541 % 19 603 M $
Geode Capital Management LLC
2.213 %
53,322,964 2.213 % 7 829 M $
Eaton Vance Management
1.766 %
42,549,943 1.766 % 6 247 M $
BlackRock Life Ltd.
1.555 %
37,465,814 1.555 % 5 501 M $
State Farm Investment Management Corp.
1.314 %
31,675,492 1.314 % 4 651 M $
JPMorgan Investment Management, Inc.
1.216 %
29,309,544 1.216 % 4 303 M $
Wells Fargo Bank NA
1.131 %
27,263,857 1.131 % 4 003 M $
Norges Bank (13F)
1.078 %
25,977,042 1.078 % 3 814 M $
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000624 %
225,649 0.000624 % 2 M $
Itaú Unibanco SA
0.000453 %
163,957 0.000453 % 2 M $
Safra Asset Management Ltda.
0.000271 %
98,000 0.000271 % 946 325 $
Bram Bradesco Asset Management S/A DTVM
0.000212 %
76,550 0.000212 % 739 196 $
Caixa DTVM SA
0.000105 %
38,082 0.000105 % 367 734 $
XP Allocation Asset Management Ltda.
0.000038 %
13,915 0.000038 % 134 369 $
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000033 %
11,813 0.000033 % 114 071 $
Western Asset Management Company DTVM Ltda.
0.000001 %
221 0.000001 % 2 134 $

Holdings

NameEquities%Valuation
182,329,550 9.52% 3,467,908,041 $
810,170 0.51% 98,071,079 $
3,670,516 4.33% 78,549,042 $
2,449,183 4.20% 60,396,853 $
4,103,430 19.00% 59,048,358 $
166,812 0.44% 54,879,480 $
814,586 0.45% 36,183,910 $
5,623,816 11.93% 33,236,753 $
1,979,173 8.46% 31,646,976 $
6,641,064 10.34% 31,279,411 $

Company contact information

Johnson & Johnson

One Johnson & Johnson Plaza

08933, New Brunswick

+732 524 0400

http://www.jnj.com
address Johnson & Johnson(JNJ)

Group companies

NameCategory and Sector
Medical Specialties
Pharmaceuticals: Major
Electronic Components
Medical Specialties
Pharmaceuticals: Major
Pharmaceuticals: Major
Household/Personal Care
Pharmaceuticals: Major
Medical Specialties

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
147 USD
Average target price
172.5 USD
Spread / Average Target
+17.38%
Consensus
  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. Company Johnson & Johnson